Quick Answer
BOSTON SCIENTIFIC CORP reported Diluted EPS of $1.94 per share for fiscal year 2025.
BOSTON SCIENTIFIC CORP Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $1.94 | +55.2% |
| 2024 | $1.25 | +16.8% |
| 2023 | $1.07 | +137.8% |
| 2022 | $0.45 | -34.8% |
| 2021 | $0.69 | +962.5% |
| 2020 | -$0.08 | -102.4% |
| 2019 | $3.33 | +179.8% |
| 2018 | $1.19 | +1387.5% |
| 2017 | $0.08 | -68.0% |
| 2016 | $0.25 | +238.9% |
| 2015 | -$0.18 | -100.0% |
| 2014 | -$0.09 | +0.0% |
| 2013 | -$0.09 | +96.9% |
| 2012 | -$2.89 | -1096.6% |
| 2011 | $0.29 | +141.4% |
| 2010 | -$0.70 | -2.9% |
| 2009 | -$0.68 | +50.0% |
| 2008 | -$1.36 | -312.1% |
| 2007 | -$0.33 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.51 | +59.4% | -3.8% |
| June 30, 2025 | $0.53 | +140.9% | +17.8% |
| March 31, 2025 | $0.45 | +36.4% | +40.6% |
| September 30, 2024 | $0.32 | -5.9% | +45.5% |
| June 30, 2024 | $0.22 | +22.2% | -33.3% |
| March 31, 2024 | $0.33 | +57.1% | -2.9% |
| September 30, 2023 | $0.34 | +183.3% | +88.9% |
| June 30, 2023 | $0.18 | +5.9% | -14.3% |
- BOSTON SCIENTIFIC CORP showed an increase of +55.2% in Diluted EPS compared to the prior fiscal year.
- Over the 2007–2025 period, BOSTON SCIENTIFIC CORP’s diluted eps has grown by 687.9% (from $0.33 per share (loss) to $1.94 per share).
- The most recent figure is from BOSTON SCIENTIFIC CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: